| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,068 |
18,848 |
$1.60M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,247 |
17,133 |
$1.07M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
9,931 |
9,719 |
$750K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
7,021 |
6,869 |
$626K |
| 99215 |
Prolong outpt/office vis |
1,240 |
1,204 |
$121K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
908 |
873 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13,300 |
10,149 |
$37K |
| S9083 |
Global fee urgent care centers |
4,386 |
3,852 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,308 |
3,136 |
$24K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
228 |
227 |
$21K |
| 99205 |
Prolong outpt/office vis |
39 |
39 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
258 |
245 |
$3K |
| 81003 |
|
1,716 |
1,575 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
159 |
152 |
$1K |
| 73610 |
|
43 |
42 |
$338.00 |
| 81025 |
|
187 |
180 |
$198.00 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
1,148 |
1,064 |
$28.50 |
| 99000 |
|
8,153 |
7,816 |
$12.60 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
15 |
$11.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
195 |
178 |
$8.99 |
| 94760 |
|
767 |
747 |
$5.82 |
| 99051 |
|
19,441 |
17,516 |
$5.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
325 |
309 |
$4.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
179 |
157 |
$0.40 |
| 73130 |
|
13 |
13 |
$0.00 |
| 99072 |
|
4,439 |
4,219 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
812 |
699 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13,409 |
12,565 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
262 |
254 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
20 |
14 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
14 |
13 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
13 |
12 |
$0.00 |
| 73630 |
|
13 |
13 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
161 |
148 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
256 |
225 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
102 |
92 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48 |
43 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
23 |
21 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
302 |
275 |
$0.00 |
| 82962 |
|
28 |
26 |
$0.00 |
| 93000 |
|
14 |
14 |
$0.00 |
| 86308 |
|
53 |
53 |
$0.00 |
| A9150 |
Non-prescription drugs |
14 |
14 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
87 |
87 |
$0.00 |